Report Detail

Request for Sample of this report

Other Global Blood Pressure Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3609560
    • |
  • 22 July, 2019
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Blood pressure disorder drug development technology and related units

Scope of the Report:
High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and salt levels, and kidney, nervous system and blood vessels.
Most hypertensive patients do not have any signs or symptoms even if their blood pressure readings reach dangerously high levels. Although a small number of people with early-onset hypertension may experience dizziness, dizziness, or more nosebleeds than normal, these symptoms and symptoms usually do not occur until the high blood pressure reaches a critical stage. There are currently 253 products under development.
The global Blood Pressure Disorders Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Pressure Disorders Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Blood Pressure Disorders Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Pressure Disorders Drug market by product type and applications/end industries.

Market Segment by Companies, this report covers
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others

Market Segment by Applications, can be divided into
Hypertension
Hypotension
Pulmonary Hypertension


Table of Contents

    1 Blood Pressure Disorders Drug Market Overview

    • 1.1 Product Overview and Scope of Blood Pressure Disorders Drug
    • 1.2 Classification of Blood Pressure Disorders Drug by Types
      • 1.2.1 Global Blood Pressure Disorders Drug Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Blood Pressure Disorders Drug Revenue Market Share by Types in 2018
      • 1.2.3 Diuretics
      • 1.2.4 Angiotensin Converting Enzyme (ACE) Inhibitors
      • 1.2.5 Angiotensin Receptor Blockers (ARBs)
      • 1.2.6 Others
    • 1.3 Global Blood Pressure Disorders Drug Market by Application
      • 1.3.1 Global Blood Pressure Disorders Drug Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hypertension
      • 1.3.3 Hypotension
      • 1.3.4 Pulmonary Hypertension
    • 1.4 Global Blood Pressure Disorders Drug Market by Regions
      • 1.4.1 Global Blood Pressure Disorders Drug Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Blood Pressure Disorders Drug (2014-2024)

    2 Company Profiles

    • 2.1 A1M Pharma AB
      • 2.1.1 Business Overview
      • 2.1.2 Blood Pressure Disorders Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Acceleron Pharma Inc
      • 2.2.1 Business Overview
      • 2.2.2 Blood Pressure Disorders Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Ache Laboratorios Farmaceuticos SA
      • 2.3.1 Business Overview
      • 2.3.2 Blood Pressure Disorders Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Actelion Pharmaceuticals Ltd
      • 2.4.1 Business Overview
      • 2.4.2 Blood Pressure Disorders Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Aerogen Ltd
      • 2.5.1 Business Overview
      • 2.5.2 Blood Pressure Disorders Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Anavex Life Sciences Corp
      • 2.6.1 Business Overview
      • 2.6.2 Blood Pressure Disorders Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 AnGes Inc
      • 2.7.1 Business Overview
      • 2.7.2 Blood Pressure Disorders Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Arena Pharmaceuticals Inc
      • 2.8.1 Business Overview
      • 2.8.2 Blood Pressure Disorders Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Ascendia Pharmaceuticals LLC
      • 2.9.1 Business Overview
      • 2.9.2 Blood Pressure Disorders Drug Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Ascendis Pharma A/S
      • 2.10.1 Business Overview
      • 2.10.2 Blood Pressure Disorders Drug Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 AVEO Pharmaceuticals Inc
      • 2.11.1 Business Overview
      • 2.11.2 Blood Pressure Disorders Drug Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Bayer AG
      • 2.12.1 Business Overview
      • 2.12.2 Blood Pressure Disorders Drug Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Bayer AG Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Bial - Portela & Ca SA
      • 2.13.1 Business Overview
      • 2.13.2 Blood Pressure Disorders Drug Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Bioblue Technologies Inc
      • 2.14.1 Business Overview
      • 2.14.2 Blood Pressure Disorders Drug Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Biogen Inc
      • 2.15.1 Business Overview
      • 2.15.2 Blood Pressure Disorders Drug Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Biogen Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Biolab Farmaceutica Ltda
      • 2.16.1 Business Overview
      • 2.16.2 Blood Pressure Disorders Drug Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 BioRestorative Therapies Inc
      • 2.17.1 Business Overview
      • 2.17.2 Blood Pressure Disorders Drug Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Boryung Pharmaceutical Co Ltd
      • 2.18.1 Business Overview
      • 2.18.2 Blood Pressure Disorders Drug Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Bristol-Myers Squibb Co
      • 2.19.1 Business Overview
      • 2.19.2 Blood Pressure Disorders Drug Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Camurus AB
      • 2.20.1 Business Overview
      • 2.20.2 Blood Pressure Disorders Drug Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Camurus AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Capricor Therapeutics Inc
      • 2.21.1 Business Overview
      • 2.21.2 Blood Pressure Disorders Drug Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Celsion Corp
      • 2.22.1 Business Overview
      • 2.22.2 Blood Pressure Disorders Drug Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Celsion Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.23 Celtaxsys Inc
      • 2.23.1 Business Overview
      • 2.23.2 Blood Pressure Disorders Drug Type and Applications
        • 2.23.2.1 Product A
        • 2.23.2.2 Product B
      • 2.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.24 Chiesi Farmaceutici SpA
      • 2.24.1 Business Overview
      • 2.24.2 Blood Pressure Disorders Drug Type and Applications
        • 2.24.2.1 Product A
        • 2.24.2.2 Product B
      • 2.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.25 Chong Kun Dang Pharmaceutical Corp
      • 2.25.1 Business Overview
      • 2.25.2 Blood Pressure Disorders Drug Type and Applications
        • 2.25.2.1 Product A
        • 2.25.2.2 Product B
      • 2.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.26 Chugai Pharmaceutical Co Ltd
      • 2.26.1 Business Overview
      • 2.26.2 Blood Pressure Disorders Drug Type and Applications
        • 2.26.2.1 Product A
        • 2.26.2.2 Product B
      • 2.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.27 CJ HealthCare Corp
      • 2.27.1 Business Overview
      • 2.27.2 Blood Pressure Disorders Drug Type and Applications
        • 2.27.2.1 Product A
        • 2.27.2.2 Product B
      • 2.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.28 Complexa Inc
      • 2.28.1 Business Overview
      • 2.28.2 Blood Pressure Disorders Drug Type and Applications
        • 2.28.2.1 Product A
        • 2.28.2.2 Product B
      • 2.28.3 Complexa Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.29 Corion Biotech Srl
      • 2.29.1 Business Overview
      • 2.29.2 Blood Pressure Disorders Drug Type and Applications
        • 2.29.2.1 Product A
        • 2.29.2.2 Product B
      • 2.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Blood Pressure Disorders Drug Market Competition, by Players

    • 3.1 Global Blood Pressure Disorders Drug Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Blood Pressure Disorders Drug Players Market Share
      • 3.2.2 Top 10 Blood Pressure Disorders Drug Players Market Share
    • 3.3 Market Competition Trend

    4 Global Blood Pressure Disorders Drug Market Size by Regions

    • 4.1 Global Blood Pressure Disorders Drug Revenue and Market Share by Regions
    • 4.2 North America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.5 South America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    5 North America Blood Pressure Disorders Drug Revenue by Countries

    • 5.1 North America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
    • 5.2 USA Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    6 Europe Blood Pressure Disorders Drug Revenue by Countries

    • 6.1 Europe Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
    • 6.2 Germany Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.3 UK Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.4 France Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Blood Pressure Disorders Drug Revenue by Countries

    • 7.1 Asia-Pacific Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
    • 7.2 China Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.5 India Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    8 South America Blood Pressure Disorders Drug Revenue by Countries

    • 8.1 South America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
    • 8.2 Brazil Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Blood Pressure Disorders Drug by Countries

    • 9.1 Middle East and Africa Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)

    10 Global Blood Pressure Disorders Drug Market Segment by Type

    • 10.1 Global Blood Pressure Disorders Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Blood Pressure Disorders Drug Market Forecast by Type (2019-2024)
    • 10.3 Diuretics Revenue Growth Rate (2014-2024)
    • 10.4 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2024)
    • 10.5 Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2014-2024)
    • 10.6 Others Revenue Growth Rate (2014-2024)

    11 Global Blood Pressure Disorders Drug Market Segment by Application

    • 11.1 Global Blood Pressure Disorders Drug Revenue Market Share by Application (2014-2019)
    • 11.2 Blood Pressure Disorders Drug Market Forecast by Application (2019-2024)
    • 11.3 Hypertension Revenue Growth (2014-2019)
    • 11.4 Hypotension Revenue Growth (2014-2019)
    • 11.5 Pulmonary Hypertension Revenue Growth (2014-2019)

    12 Global Blood Pressure Disorders Drug Market Size Forecast (2019-2024)

    • 12.1 Global Blood Pressure Disorders Drug Market Size Forecast (2019-2024)
    • 12.2 Global Blood Pressure Disorders Drug Market Forecast by Regions (2019-2024)
    • 12.3 North America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.4 Europe Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.6 South America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Blood Pressure Disorders Drug. Industry analysis & Market Report on Blood Pressure Disorders Drug is a syndicated market report, published as Global Blood Pressure Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Blood Pressure Disorders Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,780.52
      		4,170.78
      		5,561.04
      		3,246.84
      		4,870.26
      		6,493.68
      		541,314.00
      		811,971.00
      		1,082,628.00
      		289,988.40
      		434,982.60
      		579,976.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo